Zura Bio Ltd [NASDAQ: ZURA] price surged by 51.94 percent to reach at $0.67.
A sum of 7740927 shares traded at recent session while its average daily volume was at 566.81K shares. Zura Bio Ltd shares reached a high of $1.96 and dropped to a low of $1.3063 until finishing in the latest session at $1.96.
The one-year ZURA stock forecast points to a potential upside of 85.66. The average equity rating for ZURA stock is currently 1.33, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Zura Bio Ltd [ZURA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZURA shares is $13.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZURA stock is a recommendation set at 1.33. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Zura Bio Ltd shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on November 04, 2024. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Neutral. The new note on the price target was released on September 05, 2024, representing the official price target for Zura Bio Ltd stock. Previously, the target price had yet another raise to $26, while Piper Sandler analysts kept a Overweight rating on ZURA stock.
The Price to Book ratio for the last quarter was 0.97, with the Price to Cash per share for the same quarter was set at 2.76.
ZURA Stock Performance Analysis:
Zura Bio Ltd [ZURA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 41.01. With this latest performance, ZURA shares gained by 63.33% in over the last four-week period, additionally plugging by 0.51% over the last 6 months – not to mention a drop of -21.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZURA stock in for the last two-week period is set at 81.13, with the RSI for the last a single of trading hit 0.1609, and the three-weeks RSI is set at 0.1288 for Zura Bio Ltd [ZURA]. The present Moving Average for the last 50 days of trading for this stock 1.1768, while it was recorded at 1.4320 for the last single week of trading, and 2.1016 for the last 200 days.
Zura Bio Ltd (ZURA) Capital Structure & Debt Analysis
According to recent financial data for Zura Bio Ltd. ( ZURA), the Return on Equity (ROE) stands at -62.34%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -47.23%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Zura Bio Ltd’s Return on Invested Capital (ROIC) is -44.93%, showcasing its effectiveness in deploying capital for earnings.
Zura Bio Ltd (ZURA) Efficiency & Liquidity Metrics
Based on Zura Bio Ltd’s (ZURA) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Zura Bio Ltd (ZURA) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Zura Bio Ltd. (ZURA) effectively leverages its workforce, generating an average of -$2070000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 8.14% and a Quick Ratio of 8.14%, indicating strong ability to cover short-term liabilities.
ZURA Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ZURA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Zura Bio Ltd go to -18.03%.
Zura Bio Ltd [ZURA] Institutonal Ownership Details
There are presently around $70.81%, or 99.96% of ZURA stock, in the hands of institutional investors. The top three institutional holders of ZURA stocks are: VR ADVISER, LLC with ownership of 6.02 million shares, which is approximately 8.0365%. SUVRETTA CAPITAL MANAGEMENT, LLC, holding 4.86 million shares of the stock with an approximate value of $$17.01 million in ZURA stocks shares; and SUVRETTA CAPITAL MANAGEMENT, LLC, currently with $$16.25 million in ZURA stock with ownership which is approximately 6.194%.
